Nakagawa K - Search Results

1

Establishment of a camptothecin analogue (CPT-11)-resistant cell line of human non-small cell lung cancer: characterization and mechanism of resistance.

Kanzawa F, Sugimoto Y, Minato K, Kasahara K, Bungo M, Nakagawa K, Fujiwara Y, Liu LF, Saijo N. Kanzawa F, et al. Among authors: nakagawa k. Cancer Res. 1990 Sep 15;50(18):5919-24. Cancer Res. 1990. PMID: 2168285

2

Establishment and characterization of cisplatin-resistant sublines of human lung cancer cell lines.

Hong WS, Saijo N, Sasaki Y, Minato K, Nakano H, Nakagawa K, Fujiwara Y, Nomura K, Twentyman PR. Hong WS, et al. Among authors: nakagawa k. Int J Cancer. 1988 Mar 15;41(3):462-7. doi: 10.1002/ijc.2910410325. Int J Cancer. 1988. PMID: 3346112

3

In vitro antitumor effect of recombinant human tumor necrotizing factor on cultured human cancer cell lines and freshly isolated lung cancer cells by the human tumor clonogenic assay.

Sasaki Y, Kanzawa F, Takahashi H, Matsushima Y, Nakano H, Nakagawa K, Hong WS, Minato K, Fujiwara Y, Saijo N. Sasaki Y, et al. Among authors: nakagawa k. Invest New Drugs. 1987 Dec;5(4):353-9. doi: 10.1007/BF00169974. Invest New Drugs. 1987. PMID: 3436740

4

Participation of poly(ADP-ribose) polymerase in the drug sensitivity in human lung cancer cell lines.

Kubo S, Matsutani M, Nakagawa K, Ogura T, Esumi H, Saijo N. Kubo S, et al. Among authors: nakagawa k. J Cancer Res Clin Oncol. 1992;118(4):244-8. doi: 10.1007/BF01208612. J Cancer Res Clin Oncol. 1992. PMID: 1315778

5

Mechanism of cross-resistance to a camptothecin analogue (CPT-11) in a human ovarian cancer cell line selected by cisplatin.

Niimi S, Nakagawa K, Sugimoto Y, Nishio K, Fujiwara Y, Yokoyama S, Terashima Y, Saijo N. Niimi S, et al. Among authors: nakagawa k. Cancer Res. 1992 Jan 15;52(2):328-33. Cancer Res. 1992. PMID: 1345810

6

Characterization of an etoposide-resistant human small-cell lung cancer cell line.

Minato K, Kanzawa F, Nishio K, Nakagawa K, Fujiwara Y, Saijo N. Minato K, et al. Among authors: nakagawa k. Cancer Chemother Pharmacol. 1990;26(5):313-7. doi: 10.1007/BF02897284. Cancer Chemother Pharmacol. 1990. PMID: 1976450

7

Decreased accumulation as a mechanism of resistance to cis-diamminedichloroplatinum(II) in human non-small cell lung cancer cell lines: relation to DNA damage and repair.

Bungo M, Fujiwara Y, Kasahara K, Nakagawa K, Ohe Y, Sasaki Y, Irino S, Saijo N. Bungo M, et al. Among authors: nakagawa k. Cancer Res. 1990 May 1;50(9):2549-53. Cancer Res. 1990. PMID: 2158392

8

Cross-resistance to tumour promoters in human cancer cell lines resistant to adriamycin or cisplatin.

Nishio K, Sugimoto Y, Nakagawa K, Niimi S, Fujiwara Y, Bungo M, Kasahara K, Fujiki H, Saijo N. Nishio K, et al. Among authors: nakagawa k. Br J Cancer. 1990 Sep;62(3):415-9. doi: 10.1038/bjc.1990.309. Br J Cancer. 1990. PMID: 2206949 Free PMC article.

9

[A mechanism of cisplatin resistance in a cisplatin resistant lung cancer cell line].

Bungo M, Nakagawa K, Saijo N. Bungo M, et al. Among authors: nakagawa k. Gan To Kagaku Ryoho. 1990 Mar;17(3 Pt 2):515-6. Gan To Kagaku Ryoho. 1990. PMID: 2321980 Japanese. No abstract available.

10

In vitro evaluation of the new anticancer agents KT6149, MX-2, SM5887, menogaril, and liblomycin using cisplatin- or adriamycin-resistant human cancer cell lines.

Ohe Y, Nakagawa K, Fujiwara Y, Sasaki Y, Minato K, Bungo M, Niimi S, Horichi N, Fukuda M, Saijo N. Ohe Y, et al. Among authors: nakagawa k. Cancer Res. 1989 Aug 1;49(15):4098-102. Cancer Res. 1989. PMID: 2472873

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,822 results

Search Page

Filters